Dogwood Therapeutics amends certificate to increase authorized shares to 200M.

Dogwood Therapeutics amended its Certificate of Incorporation to increase total authorized shares to 200 million, comprising 195 million common shares and 5 million preferred shares. The amendment provides flexibility for future capital raises and equity transactions.